We have analysed the genes borne on a 6.0 kb Hind111 fragment cloned from the chromosome of Clostridium botulinum type E strain Mashike. This fragment, cloned within plasmid pU9EMH, contains part of the structural gene for botulinum toxin type E neurotoxin as well as the entire structural gene for a nontoxic component of botulinum type E progenitor neurotoxin gene, ent-120. ent-120 is transcribed in the same direction as the neurotoxin gene and consists of one open reading frame encoding 1162 amino acid residues. Western blotting with anti-nontoxic component sera demonstrates that ent-120 encodes a protein of 120 kDa which forms part of the nontoxic component. ent-120 is homologous to an analogous gene found in botulinum type C strains (69.3% identity at the nucleotide level and 56.1 % at the amino acid level). Two stretches of amino acids at the N-terminus of the ent-120 protein are highly homologous to amino acid sequences within the type E neurotoxin. The stop codon of the ent-120 gene is situated 27 nucleotides upstream from the start codon of the neurotoxin gene.
Introduction
Botulinum toxins, produced by Clostridium botulinum, are extremely potent neurotoxins which inhibit the release of acetylcholine at the neuromuscular junction. They are classified into seven groups (A to G), based on the antigenicity of the toxin. The 7s neurotoxin is synthesized as a single polypeptide chain of molecular mass 150 kDa, which undergoes cleavage to form a dichain molecule linked through a disulphide bond. The heavy chain (100 kDa) correlates with the binding of toxin to peripheral synapses, and the light chain is associated with the intracellular activity of blocking acetylcholine release . These toxins are produced as progenitor toxins of large molecular sizes: of 12s (M toxin), 16s (L toxin) and 19s (LL toxin) in culture supernatants. Three di erent molecular forms have been demonstrated in botulinum type A toxin (Sugii & Sakaguchi, 1975) .
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is exclusively composed of M toxin (Kitamura et al., 1968) . L and LL toxins show haemagglutinin activity, but M toxin does not (Ohishi & Sakaguchi, 1980) . Molecular dissociation of these progenitor toxins into toxic and nontoxic components occurs in alkaline conditions (Ohishi & Sakaguchi, 1980) . The nontoxic component of L or LL toxin is formed by conjugation of the nontoxic component of M toxin with the haemagglutinin. It has been suggested that the nontoxic components are necessary to maintain oral toxicity or to cause food poisoning because they prevent the 7s neurotoxin from degradation by gastric juices at low pH (Ohishi et al., 1977; Ohishi & Sakaguchi, 1980) . The molecular composition of the nontoxic fractions is not clear, but they appear to contain haemagglutinin and other macromolecules.
We have previously cloned and determined the complete nucleotide sequences of the structural genes for the haemagglutinin subcomponent (HA-33) and a nontoxic-nonHA component (nontoxic component of M toxin) of C. botulinum type C progenitor toxin . In other types of C. botulinum, the molecular constitution of the nontoxic component is less clear.
Type E progenitor toxin (M toxin) consists of a nontoxic component and the neurotoxin (Kitamura et al., 1968) . The nontoxic component contains no haem-N . Fujii and others agglutinin activity. In this paper, we describe the cloning of the gene encoding the nontoxic component of M toxin from chromosomal DNA of C. botulinum type E strain Mashike.
Methods
Rocombinant plasmids for DNA sequencing and Western blotting anal-ysis. The recombinant plasmid pU9EMH contains a 6.0 kb Hind111 fragment encoding the entire light chain and the N-terminal portion of the heavy chain of botulinum type E neurotoxin . pU9EMH DNA was digested with XbaI and KpnI, then deleted by using a Takara deletion kit containing exonuclease 111, Mungbean nuclease and Klenow enzyme (Takara Shuzo Co.). Escherichia coli MV 1184 cells transformed with the deleted pU9EMH were plated on TY agar plates (0.8 O h , w/v, tryptone, 0.5 YO yeast extract, 0.5 YO NaC1, 1.5 % agar, 50 pg ampicillin ml-'). Plasmids containing deletions were prepared by alkaline lysis of transformed E. coli MV 1184, and DNA fragments with appropriate sizes were selected by agarose gel electrophoresis.
Western blotting and DNA sequencing. Cultures of E. coli MV 1184 transformed with deletion mutants were grown in liquid medium and lysed by sonication ; the protein products were separated by SDS-PAGE, and Western blot analysis was carried out as described previously (Fujii et al., 1991 Tsuzuki et al., 1990) . Anti-type E nontoxic component rabbit serum (7S-NT), which reacts with the nontoxic component of botulinum type E progenitor toxin (Yokosawa et al., 1986) , but not with neurotoxin, and the monoclonal antibody (EL161-38) specific for type E neurotoxin were used in Western blot analyses. To reduce background, a 1 : 1000-diluted antiserum was treated with about 1 mg ml-' of E. coli MV 1184 extracts for 30 min before adding to the filter.
The deletion mutants of pU9EMH described above were used to determine the DNA sequence of the nontoxic component gene of botulinum type E progenitor toxin. DNA sequences were determined by the dideoxy chain-termination method using [ c~-~~S ]~A T P (NEN Products) and a T7 DNA sequencing kit (Pharmacia LKB Biotechnology), in accordance with the manufacturer's instructions (Fujii et al., , 1991 .
Results

Western blotting analysis of gene products
The proteins expressed from E. coli MV 1184 containing pU9EMH were analysed by SDS-PAGE and Western blotting. In addition to the 100 kDa protein fragment of type E neurotoxin identified with monoclonal antibody EL161-38 , pU9EMH also produced a protein band of approximately 120 kDa which reacted with anti-7S-NT rabbit serum recognizing the nontoxic component of type E progenitor toxin (M toxin) (Fig.  1 a) . The 120 kDa protein did not react with monoclonal antibody EL161-38 recognizing type E neurotoxin. The gene encoding the 120 kDa protein was designated as ent-120.
A series of plasmids containing various deletions of the 6.0 kb DNA fragment was prepared. The gene products from these deletion mutants were analysed by Western blotting using 7S-NT serum. Three plasmids containing a DNA fragment larger than 3.7 kb (pU9EH-D16, pU9EH-DO and pU9EMH) produced the 120 kDa protein. Lower molecular mass proteins were produced by plasmids containing inserts smaller than 3-7 kb (pU9EH-D23, pU9EH-D29 and pU9EH-Dl2) (Fig. 1 b) . These results suggested that the entire ent-120 gene was located within the 3.7 kb fragment contained in pU9EH-D16. Furthermore, deletion of about 500 bp from the 5'-terminus of the 6.0 kb fragment (pU9EH-RD1) resulted in no expression of the 120 kDa protein, suggesting that in this construct the promoter region has been deleted. Therefore, we concluded that the genes for ent-120 and type E neurotoxin were probably transcribed in the same direction (Fig. 1 b) . In contrast to the plasmids containing deletions of the toxin gene, pU9EH-RD 1 still produced the 100 kDa toxin polypeptide. Thus although the putative promoter for ent-120 has been deleted, the promoter region necessary for the expression of the 100 kDa toxin gene in E. coli is still present.
Nucleotide and deduced amino acid sequences of ent-120 gene
The complete DNA sequence of the ent-120 gene was determined and is shown in Fig. 2 . One open reading frame was composed of 1162 amino acid residues (3486 nucleotides), initiating at nucleotide position 163 with an ATG codon and terminating at position 3649 with a TAA stop codon. The molecular mass calculated from the deduced amino acid sequence was 136849.3 Da, a value slightly higher than that estimated from the blotting analysis described above. The N-terminal amino acid sequence of the ent-120 gene was very similar (22 out of 30 amino acid residues identical) to that of the botulinum type E nontoxic component reported by Somers & DasGupta (1991) . The amino acid residues which differ are marked with stars in Fig. 2 . The high degree of identity between the amino acid sequence of the nontoxic component and the deduced sequence of ent-120 strongly suggests that ent-120 encodes the nontoxic component of botulinum type E progenitor toxin.
In the 5'antranslated region of the ent-120 gene, sequences homologous to the Shine-Dalgarno and to the -10 regions of typical E. coli promoters were found 16 bp and 107 bp upstream from the translation initiation start codon respectively (Fig. 2) . There was no similarity in the promoter region between the botulinum type E and type C nontoxic component genes. However, sequences resembling the promoters of the C. hotulinum type A and Clostridium tetani neurotoxin genes were detectable in those regions of both the type E and type C nontoxic component genes (Fig. 2) . These sequences may act as promoters in C. botulinum strains. Furthermore, the -35 region (TTTACA) of the lactose operon gene was also found near the putative -35 regions of both nontoxic component genes (indicated with a box in Fig.  2) . Surprisingly, as shown in Fig. 2 , the C. botulinum ent-120 gene was separated from the type E neurotoxin gene by only 27 nucleotides, although no promoter-like sequence was found in this region. A similar result was found with the type C neurotoxin and nontoxic component genes .
Comparative studies on amino acid sequences between hotulinum type E and type C nontoxic component
Sequence comparison of type E and type C nontoxic components reveals approximately 69.3 % identity at the nucleotide level and 56.1 % at the amino acid level. Amino acid sequences homologous of those of type C are underlined in Fig. 2 . This is an interesting result in the light of the low homology at the amino acid level between the neurotoxins of C. botulinum types E and C (Poulet et al., 1992; Whelan et al., 1992b) . This suggests that the nontoxic components are composed of highly conserved amino acid sequences, in contrast to the botulinum neurotoxins. The two nontoxic components have similar hydrophobicity patterns (data not shown). We reported previously that the N-terminal amino acid sequences of the type C nontoxic component and type C neurotoxin showed high homology . Similar homology in the N-terminal amino acid sequences is also found between the type E nontoxic component and botulinum toxins types A, B, C, D and E, and tetanus neurotoxins (Fig. 3) . Nevertheless, there is no immunological cross-reaction between type E nontoxic component and other neurotoxins (data not shown).
Discussion
Type E botulinum neurotoxin is produced as a progenitor toxin (M toxin) in culture supernatants (Kitamura et al., 1968) . The progenitor toxin dissociates into the neurotoxin and the nontoxic component in alkaline conditions (Kitamura et al., 1968; Sugii & Sakaguchi, 1975) . In this paper, we report the nucleotide sequence of the structural gene for the type E nontoxic component, and the possibility of polycistronic transcription of the botulinum type E nontoxic component and neurotoxin genes. The botulinum type E nontoxic component gene has one open reading frame (3486 nucleotides) coding for 3 . Homology of deduced amino acid sequence among botulinum nontoxic components and neurotoxins. The sequence of type E nontoxic component is compared with those of botulinum type C nontoxic component , and botulinum type A (Binz et al., 1990a; Thompson et al., 1990) , type B (Whelan et al., 1992a) , type C , type D (Binz et al., 1990h) , type E (Fujii el al., 1992; Poulet et al., 1992; Whelan et al., 1992b) and tetanus (Eisel et al., 1986; Fairweather & Lyness, 1986) neurotoxins.
1162 amino acid residues. The type E nontoxic component is shorter than type C nontoxic component (1 196 amino acid residues). Although the entire light chains of type E and type C neurotoxins are produced in E. coli MV 1 184 cells harbouring recombinant plasmids of pU9EMH and pCL8, respectively Fujii et al., 1992) , the mechanism of expression of the nontoxic component from these plasmids may be different. The type E nontoxic component is expressed in E. coli cells transformed with pU9EMH, but that of type C (pCL8) is never found . It is possible therefore that there are some differences in the activity of the promoter regions between type E and type C nontoxic component genes, as recognized by E. coli RNA polymerase. Comparative studies revealed that there is very little similarity in these promoter regions. It is still unclear which nucleotide sequences are essential for the expression of genes in C. botulinum. For the expression of type E progenitor toxin in E. coli cells, the neurotoxin and the nontoxic component are produced or transcribed independently because the recombinant plasmid pU9EH-RD1 (Fig. l) , which lacks 500 bp of the putative promoter region of ent-120, produces a 100 kDa N-terminal fragment of the type E neurotoxin. This is also confirmed by our previous finding that the 33 kDa fragment of the type E neurotoxin is expressed from a plasmid containing a 1 kb EcoRI 5'-region fragment of the type E neurotoxin gene . A similar result is obtained from the plasmid containing a 2.8 kb Hind111 5'-region fragment (1.9 kb of 5'-noncoding region and 0.9 kb of 5'-coding region) of the type C neurotoxin gene (unpublished data). However, it is clear that there is only 27 bp between the stop codon of the type E nontoxic component gene and the start codon of the type E neurotoxin gene. Therefore, it is likely that some nucleotide sequence in the nontoxic component gene may work as a promoter for the neurotoxin gene in E. coli. Such a promoter region has been proposed by Fujii et al. (1990) and Whelan et al. (1992 b) : the ' -10' region located between nucleotides 3535 and 3540. However, such a sequence may not function as a promoter in C. botulinum. We suggest that the nontoxic N . Fujii and others component and neurotoxin genes are transcribed by a polycistronic mRNA species initiated from a promoter located in the 5'-untranslated region of the nontoxic component gene in C. botulinum. These results obtained from the nontoxic components of types E and C contrast with the work of Binz et al. (1990a) , who showed that the transcription of botulinum type A neurotoxin initiates from just upstream of the start codon of the toxin gene. Thus the transcription system may vary in each type of C. botulinum. Primer extension and Northern blot experiments using mRNA from C. botulinum type C and E strains will be necessary to locate the transcriptional start sites and the size of mRNA from the neurotoxin and ent-120 genes. Similarity between the type E and type C nontoxic components indicates that the nontoxic component may be highly conserved in C. botulinum, and it may play an important role. The N-terminal regions of both the nontoxic component and neurotoxins of type C showed high homology . In the type E progenitor toxin, highly homologous regions are detectable between the nontoxic component and neurotoxin (Fig. 3) . As the nontoxic component is closely associated with oral toxicity (Ohishi et al., 1977; Ohishi & Sakaguchi, 1980) , this component might act to protect neurotoxin from protease.
